S-EPMC11000280 - Pembrolizumab-based first-line treatment for PD-L1-positive, recurrent or metastatic head and neck squamous cell carcinoma: a retrospective analysis - OmicsDI

Unknown

Dataset Information

Pembrolizumab-based first-line treatment for PD-L1-positive, recurrent or metastatic head and neck squamous cell carcinoma: a retrospective analysis

ABSTRACT:

SUBMITTER: Cirillo A

PROVIDER: S-EPMC11000280 | biostudies-literature | 2024 Jan

REPOSITORIES: biostudies-literature